Elevated galectin-1 (LGALS1) expression in MM CD138+ cells has been associated with poorer patient outcomes, while galectin-3 exhibits variable expression across different lineages and in primary MM cells and has been implicated in angiogenesis and metastasis. This evidence concerns the gene SDC1 and Miyoshi myopathy.